Skip to main content
  • Sign in
    Welcome !
    My account
    Logout

SYNOVUS FINANCIAL CORP (SNV-PE) Stock Forecast 2025 - AI Price Prediction & Analysis

SYNOVUS FINANCIAL CORP (SNV-PE) AI Stock Price Forecast & Investment Analysis

SYNOVUS FINANCIAL CORP Stock Price Chart and Technical Analysis

Loading SYNOVUS FINANCIAL CORP interactive price chart and technical analysis...

SYNOVUS FINANCIAL CORP (SNV-PE) - Comprehensive Stock Analysis & Investment Research

Deep dive into SYNOVUS FINANCIAL CORP's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about SYNOVUS FINANCIAL CORP, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For SYNOVUS FINANCIAL CORP: SYNOVUS FINANCIAL CORP operates in the Finance sector, establishing it as a mid-cap growth opportunity.

SYNOVUS FINANCIAL CORP (Stock Symbol: SNV-PE) is a leading company in the Finance sector , specifically operating within the National Commercial Banks industry.

.

The company has established itself as a growing mid-cap opportunity with strong fundamentals.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing SYNOVUS FINANCIAL CORP's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SYNOVUS FINANCIAL CORP: With $2783M in annual revenue, the company demonstrates developing profitability.

Annual Revenue: $2783 million .

Market Capitalization: $3726 million - Classified as a mid-cap growth stock with balanced risk-reward profile.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for SYNOVUS FINANCIAL CORP stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For SYNOVUS FINANCIAL CORP: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for SYNOVUS FINANCIAL CORP stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: SYNOVUS FINANCIAL CORP's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For SYNOVUS FINANCIAL CORP: Market positioning analysis based on available financial and operational metrics.

SYNOVUS FINANCIAL CORP strategically competes in the highly dynamic National Commercial Banks marketplace, establishing itself as a promising mid-cap growth opportunity with strong fundamentals and expanding market share .

SYNOVUS FINANCIAL CORP (SNV-PE) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for SYNOVUS FINANCIAL CORP stock analysis.

Loading SYNOVUS FINANCIAL CORP comprehensive fundamental analysis and insider trading data...

Deep dive into SYNOVUS FINANCIAL CORP's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if SYNOVUS FINANCIAL CORP stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For SYNOVUS FINANCIAL CORP: With a P/E ratio of 4.75, the market sees the stock as potentially undervalued.

P/E Ratio 4.75x
P/B Ratio 0.66x
Market Cap $3726M
Dividend Yield 5.84%
EPS $5.22
Book Value/Share $39.77
Revenue/Share $19.70
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently SYNOVUS FINANCIAL CORP converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For SYNOVUS FINANCIAL CORP:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess SYNOVUS FINANCIAL CORP's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For SYNOVUS FINANCIAL CORP:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal SYNOVUS FINANCIAL CORP's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For SYNOVUS FINANCIAL CORP:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively SYNOVUS FINANCIAL CORP uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For SYNOVUS FINANCIAL CORP:

Understanding Financial Statement Data

What these metrics mean: Key figures from SYNOVUS FINANCIAL CORP's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For SYNOVUS FINANCIAL CORP: With annual revenue of $2783M, SYNOVUS FINANCIAL CORP operates at significant scale.

Income Statement ($ Millions)
Total Revenue $2783M
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Dividends Per Share $1.54
Payout Ratio 0.3%
Shares Outstanding 141M

Latest SYNOVUS FINANCIAL CORP Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting SYNOVUS FINANCIAL CORP (SNV-PE) stock price and investment outlook.

, source: SFGATE

COLUMBUS, Ga. (AP) — COLUMBUS, Ga. (AP) — Synovus Financial Corp. (SNV) on Wednesday reported third-quarter earnings of $197 million. The Columbus, Georgia-based bank said it had earnings of $1.33 per ...

SYNOVUS FINANCIAL CORP Competitors & Peer Analysis - Finance Sector

Comparative analysis of SYNOVUS FINANCIAL CORP against industry peers and competitors in the Finance sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
ALRS Unlock Forecast - 30 Days FREE Trial $533M 13.8x 1.0x
AMJB Unlock Forecast - 30 Days FREE Trial $80000M 1.4x 0.2x
AMTB Unlock Forecast - 30 Days FREE Trial $750M 203.9x 0.8x
AROW Unlock Forecast - 30 Days FREE Trial $434M 14.2x 1.1x
ASRV Unlock Forecast - 30 Days FREE Trial $50M 13.5x 0.5x
ATLO Unlock Forecast - 30 Days FREE Trial $175M 12.8x 0.9x
BAC Unlock Forecast - 30 Days FREE Trial $375106M 13.4x 1.3x
BAC-PB Unlock Forecast - 30 Days FREE Trial $189784M 6.8x 0.6x
BAC-PE Unlock Forecast - 30 Days FREE Trial $160037M 5.7x 0.5x
BAC-PK Unlock Forecast - 30 Days FREE Trial $185694M 6.6x 0.6x
BAC-PL Unlock Forecast - 30 Days FREE Trial $9450160M 336.6x 31.5x
BAC-PM Unlock Forecast - 30 Days FREE Trial $170672M 6.1x 0.6x
BAC-PN Unlock Forecast - 30 Days FREE Trial $159219M 5.7x 0.5x
BAC-PO Unlock Forecast - 30 Days FREE Trial $136984M 4.9x 0.5x
BAC-PP Unlock Forecast - 30 Days FREE Trial $129621M 4.6x 0.4x
BAC-PQ Unlock Forecast - 30 Days FREE Trial $135050M 4.8x 0.5x
BAC-PS Unlock Forecast - 30 Days FREE Trial $151708M 5.4x 0.5x
BACRP Unlock Forecast - 30 Days FREE Trial $1623055M 57.8x 5.4x
BANC Unlock Forecast - 30 Days FREE Trial $2276M 15.4x 0.7x
BANC-PF Unlock Forecast - 30 Days FREE Trial $3646M 24.7x 1.1x
BANF Unlock Forecast - 30 Days FREE Trial $3816M 16.3x 2.2x
BANFP Unlock Forecast - 30 Days FREE Trial $871M 3.7x 0.5x
BFC Unlock Forecast - 30 Days FREE Trial $1197M 17.3x 2.0x
BHRB Unlock Forecast - 30 Days FREE Trial $879M 8.4x 1.1x
BML-PG Unlock Forecast - 30 Days FREE Trial $152526M 5.4x 0.5x
BML-PH Unlock Forecast - 30 Days FREE Trial $151560M 5.4x 0.5x
BML-PJ Unlock Forecast - 30 Days FREE Trial $156319M 5.6x 0.5x
BML-PL Unlock Forecast - 30 Days FREE Trial $152080M 5.4x 0.5x
BOKF Unlock Forecast - 30 Days FREE Trial $8062M 15.0x 1.4x
C Unlock Forecast - 30 Days FREE Trial $183510M 12.9x 0.9x
CAC Unlock Forecast - 30 Days FREE Trial $604M 12.3x 0.9x
CARE Unlock Forecast - 30 Days FREE Trial $416M 13.3x 1.0x
CBNA Unlock Forecast - 30 Days FREE Trial $194M x 1.2x
CBNK Unlock Forecast - 30 Days FREE Trial $479M 11.1x 1.3x
CBU Unlock Forecast - 30 Days FREE Trial $2904M 14.9x 1.5x
CFBK Unlock Forecast - 30 Days FREE Trial $145M 8.0x 0.8x
CFR Unlock Forecast - 30 Days FREE Trial $7768M 12.8x 1.9x
CFR-PB Unlock Forecast - 30 Days FREE Trial $1154M 1.9x 0.3x
CHCO Unlock Forecast - 30 Days FREE Trial $1697M 13.9x 2.2x
CMA Unlock Forecast - 30 Days FREE Trial $9748M 13.5x 1.3x
COF Unlock Forecast - 30 Days FREE Trial $129918M 16.5x 1.2x
COF-PI Unlock Forecast - 30 Days FREE Trial $12752M x 0.1x
COF-PJ Unlock Forecast - 30 Days FREE Trial $12317M x 0.1x
COF-PK Unlock Forecast - 30 Days FREE Trial $11844M x 0.1x
COF-PL Unlock Forecast - 30 Days FREE Trial $11192M x 0.1x
COF-PN Unlock Forecast - 30 Days FREE Trial $11134M x 0.1x
C-PN Unlock Forecast - 30 Days FREE Trial $59098M 4.2x 0.3x
DCOM Unlock Forecast - 30 Days FREE Trial $1221M 27.7x 0.9x
DCOMG Unlock Forecast - 30 Days FREE Trial $1152M 26.1x 0.8x
DCOMP Unlock Forecast - 30 Days FREE Trial $832M 18.9x 0.6x
ENBP Unlock Forecast - 30 Days FREE Trial $112M 6.5x 0.8x
FCF Unlock Forecast - 30 Days FREE Trial $1639M 12.2x 1.1x
FDBC Unlock Forecast - 30 Days FREE Trial $247M 10.4x 1.1x
FFBC Unlock Forecast - 30 Days FREE Trial $2245M 9.4x 0.9x
FHN Unlock Forecast - 30 Days FREE Trial $10343M 12.3x 1.2x
FHN-PC Unlock Forecast - 30 Days FREE Trial $12988M 15.4x 1.5x
FHN-PE Unlock Forecast - 30 Days FREE Trial $13405M 15.9x 1.5x
FHN-PF Unlock Forecast - 30 Days FREE Trial $9471M 11.2x 1.1x
FIISO Unlock Forecast - 30 Days FREE Trial $2577M x 4.3x
FISI Unlock Forecast - 30 Days FREE Trial $522M 8.1x 0.9x
FMCB Unlock Forecast - 30 Days FREE Trial $738M 8.2x 1.2x
FNB Unlock Forecast - 30 Days FREE Trial $5313M 11.4x 0.8x
FNLC Unlock Forecast - 30 Days FREE Trial $276M 9.2x 1.0x
FRME Unlock Forecast - 30 Days FREE Trial $2019M 8.9x 0.9x
FRMEP Unlock Forecast - 30 Days FREE Trial $1503M 6.7x 0.6x
FSUN Unlock Forecast - 30 Days FREE Trial $1074M 12.1x 1.0x
FULT Unlock Forecast - 30 Days FREE Trial $3126M 9.7x 0.9x
FULTP Unlock Forecast - 30 Days FREE Trial $3634M 11.2x 1.1x
FUNC Unlock Forecast - 30 Days FREE Trial $221M 9.3x 1.2x
GNTY Unlock Forecast - 30 Days FREE Trial $553M 15.3x 1.7x
HAFC Unlock Forecast - 30 Days FREE Trial $703M 10.8x 0.9x
HBAN Unlock Forecast - 30 Days FREE Trial $22422M 10.6x 1.1x
HBANL Unlock Forecast - 30 Days FREE Trial $36835M 17.5x 1.8x
HBANM Unlock Forecast - 30 Days FREE Trial $33844M 16.0x 1.6x
HBANP Unlock Forecast - 30 Days FREE Trial $26696M 12.7x 1.3x
HOPE Unlock Forecast - 30 Days FREE Trial $1317M 31.6x 0.6x
HWBK Unlock Forecast - 30 Days FREE Trial $206M 10.0x 1.3x
JPM Unlock Forecast - 30 Days FREE Trial $838599M 14.8x 2.4x
JPM-PC Unlock Forecast - 30 Days FREE Trial $71882M 1.3x 0.2x
JPM-PD Unlock Forecast - 30 Days FREE Trial $70506M 1.3x 0.2x
JPM-PJ Unlock Forecast - 30 Days FREE Trial $58877M 1.0x 0.2x
JPM-PK Unlock Forecast - 30 Days FREE Trial $56573M 1.0x 0.2x
JPM-PL Unlock Forecast - 30 Days FREE Trial $57416M 1.0x 0.2x
JPM-PM Unlock Forecast - 30 Days FREE Trial $53062M 0.9x 0.2x
KEY Unlock Forecast - 30 Days FREE Trial $18572M 105.5x 1.0x
KEY-PI Unlock Forecast - 30 Days FREE Trial $27747M 157.7x 1.4x
KEY-PJ Unlock Forecast - 30 Days FREE Trial $24615M 139.9x 1.3x
KEY-PK Unlock Forecast - 30 Days FREE Trial $24582M 139.7x 1.3x
KEY-PL Unlock Forecast - 30 Days FREE Trial $27758M 157.7x 1.4x
LARK Unlock Forecast - 30 Days FREE Trial $152690M 9357.1x 1029.1x
LCNB Unlock Forecast - 30 Days FREE Trial $207M 9.8x 0.8x
MER-PK Unlock Forecast - 30 Days FREE Trial $192387M 6.9x 0.6x
MFG Unlock Forecast - 30 Days FREE Trial $15890M x 0.0x
MRBK Unlock Forecast - 30 Days FREE Trial $159M 8.7x 0.9x
MZHOF Unlock Forecast - 30 Days FREE Trial $75377M x 0.0x
NBHC Unlock Forecast - 30 Days FREE Trial $1373M 11.5x 1.0x
NBTB Unlock Forecast - 30 Days FREE Trial $1937M 14.5x 1.1x
NEWT Unlock Forecast - 30 Days FREE Trial $276M 5.2x 0.9x
NEWTG Unlock Forecast - 30 Days FREE Trial $658M 12.3x 2.1x
NEWTH Unlock Forecast - 30 Days FREE Trial $652M 12.2x 2.1x
NEWTI Unlock Forecast - 30 Days FREE Trial $665M 12.5x 2.1x
NEWTZ Unlock Forecast - 30 Days FREE Trial $661M 12.4x 2.1x
NIC Unlock Forecast - 30 Days FREE Trial $1825M 13.5x 1.5x
NKSH Unlock Forecast - 30 Days FREE Trial $183M 16.3x 1.1x
NWBI Unlock Forecast - 30 Days FREE Trial $1535M 10.7x 0.9x
OCFC Unlock Forecast - 30 Days FREE Trial $1013M 11.6x 0.6x
ONB Unlock Forecast - 30 Days FREE Trial $7680M 13.5x 0.9x
ONBPO Unlock Forecast - 30 Days FREE Trial $9815M 17.3x 1.2x
ONBPP Unlock Forecast - 30 Days FREE Trial $9835M 17.3x 1.2x
OPHC Unlock Forecast - 30 Days FREE Trial $46M 3.2x 0.4x
PFIS Unlock Forecast - 30 Days FREE Trial $464M 13.8x 0.9x
PNFP Unlock Forecast - 30 Days FREE Trial $6571M 11.0x 1.0x
PNFPP Unlock Forecast - 30 Days FREE Trial $1947M 3.3x 0.3x
PRK Unlock Forecast - 30 Days FREE Trial $2510M 15.0x 2.3x
RF Unlock Forecast - 30 Days FREE Trial $21132M 10.2x 1.1x
RF-PC Unlock Forecast - 30 Days FREE Trial $22127M 10.7x 1.2x
RF-PE Unlock Forecast - 30 Days FREE Trial $16571M 8.0x 0.9x
RF-PF Unlock Forecast - 30 Days FREE Trial $22969M 11.1x 1.2x
SFNC Unlock Forecast - 30 Days FREE Trial $2299M 14.4x 0.7x
SFST Unlock Forecast - 30 Days FREE Trial $337M 15.4x 1.0x
SHBI Unlock Forecast - 30 Days FREE Trial $515M 9.6x 0.9x
SMBK Unlock Forecast - 30 Days FREE Trial $587M 14.1x 1.1x
SNNF Unlock Forecast - 30 Days FREE Trial $19M x 0.8x
SNV Unlock Forecast - 30 Days FREE Trial $6124M 7.8x 1.1x
SNV-PD Unlock Forecast - 30 Days FREE Trial $3495M 4.5x 0.6x
SNV-PE Unlock Forecast - 30 Days FREE Trial $3726M 4.8x 0.7x
STEL Unlock Forecast - 30 Days FREE Trial $1492M 13.5x 0.9x
TBBK Unlock Forecast - 30 Days FREE Trial $3355M 15.0x 3.9x
TRMK Unlock Forecast - 30 Days FREE Trial $2255M 10.4x 1.1x
UBFO Unlock Forecast - 30 Days FREE Trial $157M 14.1x 1.2x
UBOH Unlock Forecast - 30 Days FREE Trial $114M 10.1x 1.4x
UMBF Unlock Forecast - 30 Days FREE Trial $8157M 15.4x 1.1x
UMBFO Unlock Forecast - 30 Days FREE Trial $2020M 3.8x 0.3x
USB Unlock Forecast - 30 Days FREE Trial $71214M 10.3x 1.2x
USB-PA Unlock Forecast - 30 Days FREE Trial $1266720M 183.6x 20.6x
USB-PH Unlock Forecast - 30 Days FREE Trial $29546M 4.3x 0.5x
USB-PP Unlock Forecast - 30 Days FREE Trial $37206M 5.4x 0.6x
USB-PQ Unlock Forecast - 30 Days FREE Trial $24659M 3.6x 0.4x
USB-PR Unlock Forecast - 30 Days FREE Trial $26208M 3.8x 0.4x
USB-PS Unlock Forecast - 30 Days FREE Trial $30436M 4.4x 0.5x
VABK Unlock Forecast - 30 Days FREE Trial $209M 11.7x 1.2x
VLY Unlock Forecast - 30 Days FREE Trial $5477M 12.1x 0.7x
VLYPN Unlock Forecast - 30 Days FREE Trial $14542M 32.1x 1.9x
VLYPO Unlock Forecast - 30 Days FREE Trial $14086M 31.1x 1.9x
VLYPP Unlock Forecast - 30 Days FREE Trial $14176M 31.3x 1.9x
VYLD Unlock Forecast - 30 Days FREE Trial $74259M 1.3x 0.2x
WABC Unlock Forecast - 30 Days FREE Trial $1186M 9.4x 1.3x
WAFD Unlock Forecast - 30 Days FREE Trial $2211M 9.8x 0.7x
WAFDP Unlock Forecast - 30 Days FREE Trial $1306M 5.8x 0.4x
WBHC Unlock Forecast - 30 Days FREE Trial $2100M 33.3x 4.0x
WBS Unlock Forecast - 30 Days FREE Trial $9039M 10.6x 1.0x
WBS-PF Unlock Forecast - 30 Days FREE Trial $3400M 4.0x 0.4x
WBS-PG Unlock Forecast - 30 Days FREE Trial $4068M 4.8x 0.4x
WFC Unlock Forecast - 30 Days FREE Trial $270514M 13.1x 1.5x
WFCNP Unlock Forecast - 30 Days FREE Trial $5824M 0.3x 0.0x
WFC-PA Unlock Forecast - 30 Days FREE Trial $63603M 3.1x 0.4x
WFC-PC Unlock Forecast - 30 Days FREE Trial $58998M 2.9x 0.3x
WFC-PD Unlock Forecast - 30 Days FREE Trial $58535M 2.8x 0.3x
WFC-PL Unlock Forecast - 30 Days FREE Trial $4015807M 195.1x 22.2x
WFC-PY Unlock Forecast - 30 Days FREE Trial $79673M 3.9x 0.4x
WFC-PZ Unlock Forecast - 30 Days FREE Trial $64311M 3.1x 0.4x
WSBC Unlock Forecast - 30 Days FREE Trial $2966M 21.9x 0.8x
WSBCP Unlock Forecast - 30 Days FREE Trial $2428M 18.0x 0.6x
WSFS Unlock Forecast - 30 Days FREE Trial $2944M 11.0x 1.1x
ZION Unlock Forecast - 30 Days FREE Trial $6927M 8.2x 1.1x
ZIONP Unlock Forecast - 30 Days FREE Trial $3178M 3.8x 0.5x

Frequently Asked Questions - SYNOVUS FINANCIAL CORP Stock Forecast

How accurate are SYNOVUS FINANCIAL CORP stock predictions?

Our AI model demonstrates 38% historical accuracy for SNV-PE predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence SYNOVUS FINANCIAL CORP stock price forecasts?

Our analysis considers SYNOVUS FINANCIAL CORP's financial metrics, Finance sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is SYNOVUS FINANCIAL CORP a good investment in 2025?

Based on our AI analysis, SYNOVUS FINANCIAL CORP shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are SYNOVUS FINANCIAL CORP forecasts updated?

SYNOVUS FINANCIAL CORP stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced SYNOVUS FINANCIAL CORP Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for SYNOVUS FINANCIAL CORP stock.

🎯 Get Premium Analysis 📊 Explore More Stocks

My Portfolio

Investment Dashboard

Loading your portfolio...